Back

Clinical events after percutaneous coronary intervention depending on dual antiplatelet therapy cessation

15 October 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Antithrombotic therapy Antithrombotic agents ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Doctor Manuel Marina Breysse

Idoven, Madrid (Spain)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor B. Picarra (Evora, PT)
Abstract
Presentation thumbnail
Doctor Y. Khomitskaya (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor B. Musumeci (Rome, IT)
Abstract
Presentation thumbnail
Doctor L. Madrona Jimenez (Seville, ES)

Access the full session

Session thumbnail
Poster Session 1 - Antithrombotic therapy

The Event

Event poster

Acute Cardiovascular Care 2016

15 October 2016 08:30 CET
You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Congress Presentation
Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources